Harmony Biosciences Holdings (HRMY) Preferred Dividend Payments (2019 - 2020)
Harmony Biosciences Holdings (HRMY) posted Preferred Dividend Payments of $6.0 million for Q3 2020, down 42.44% sequentially from $10.4 million in Q2 2020, and down 33.39% YoY from $9.0 million in Q4 2019.
Harmony Biosciences Holdings (HRMY) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
Harmony Biosciences Holdings has reported Preferred Dividend Payments for 2 years, with the latest figure at $6.0 million in Q3 2020.
- Quarterly Preferred Dividend Payments fell 33.39% year-over-year to $6.0 million in Q3 2020, while the trailing twelve-month figure through Dec 2020 was $26.9 million (changed N/A YoY) and the FY2020 annual result came in at $26.9 million, down 23.64% from the prior year.
- Preferred Dividend Payments eased to $6.0 million in Q3 2020 per HRMY's latest filing, from $10.4 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $10.4 million in Q2 2020 and troughed at $6.0 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 6.01 Mn |
| Jun 30, 2020 | 10.45 Mn |
| Mar 31, 2020 | 10.45 Mn |
| Dec 31, 2019 | 9.58 Mn |
| Sep 30, 2019 | 9.03 Mn |